Article Correctness Is Author's Responsibility: Gocovri Treatment Effect Maintained for up to 2 Years in PD Patients With Dyskinesia

The article below may contain offensive and/or incorrect content.

The open-label safety study included patients from 3 Gocovri dyskinesia efficacy trials (N=223) and evaluated the long-term safety and tolerability of the treatment.